ANR vs ANW: Side-by-Side Comparison
Compare Anatara Lifesciences Ltd (ANR) and Immuron Limited (ANW) side by side: market cap AUD 3.16M vs EUR 3.55M. Financials, growth and model signals on Bullrun.
| Metric | ANR | ANW |
|---|---|---|
| Company | Anatara Lifesciences Ltd | Immuron Limited |
| Country / Exchange | Australia · AU | Australia · F |
| Sector | Healthcare | Healthcare |
| Industry | Biotechnology | Biotechnology |
| Market cap | AUD 3.16M | EUR 3.55M |
| P/E ratio | — | — |
| Dividend yield | — | — |
| Valuation model | — | — |
| Revenue (FY2025) | AUD 970.00K | EUR 7.29M |
| Revenue growth YoY | +51.6% | +48.6% |
| Net income | AUD -1.95M | EUR -5.22M |
| Gross margin | -64.9% | 65.4% |
| Diluted EPS | -0.01 | -0.02 |
Figures are in each company's reporting currency — compare growth rates and margins rather than raw amounts.